Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Peter Kronenberger"'
Autor:
Alfiah Noor, Gudrun Walser, Matthijs Wesseling, Philippe Giron, Albert-Menno Laffra, Fatima Haddouchi, Jacques De Grève, Peter Kronenberger
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-7 (2018)
Abstract Objective Our aim was to produce a mono-biotinylated single domain antibody (‘nanobody’) specific for the epidermal growth factor receptor (EGFR), which is overexpressed in many cancer cells. The binding of the nanobody and its function
Externí odkaz:
https://doaj.org/article/41de9e26defe4117a52d47dfa64ff3d8
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-2 (2020)
Following publication of the original article [1], the authors reported that there was an error in Figure 9, which contained a misplaced picture. The authors confirm that all of the published results and conclusions of the paper remain unchanged, as
Externí odkaz:
https://doaj.org/article/9a15851c24214bd9abc05a2d09ea406a
Autor:
Gang Chen, Alfiah Noor, Peter Kronenberger, Erik Teugels, Ijeoma Adaku Umelo, Jacques De Grève
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59708 (2013)
Epidermal growth factor receptor (EGFR) and c-MET receptors are expressed on many non-small cell lung cancer (NSCLC) cells. Current single agent therapeutic targeting of a mutant EGFR has a high efficacy in the clinic, but is not curative. Here, we i
Externí odkaz:
https://doaj.org/article/3ccdb423d083432cac895991f695483e
Autor:
Gang Chen, Ijeoma Adaku Umelo, Shasha Lv, Erik Teugels, Karel Fostier, Peter Kronenberger, Alex Dewaele, Jan Sadones, Caroline Geers, Jacques De Grève
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e60317 (2013)
Aberrant expression of microRNA-146a (miR-146a) has been reported to be involved in the development and progression of various types of cancers. However, its role in non-small cell lung cancer (NSCLC) has not been elucidated. The aim of this study wa
Externí odkaz:
https://doaj.org/article/5afe555df6d7441d85d1f9ee2a956a74
Autor:
Peter Kronenberger, Erik Teugels, Alfiah Noor, Ijeoma Adaku Umelo, Philippe Giron, Elly De Vlieghere, Jacques De Greve, Olivier De Wever
Publikováno v:
Oncotarget
ONCOTARGET
ONCOTARGET
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis in cancer cells without causing damage to normal cells. However, some tumors are resistant to TRAIL monotherapy and clinical studies assessing targeted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ae2a3253a75d3184cd9decf09a2400
http://europepmc.org/articles/PMC6033352
http://europepmc.org/articles/PMC6033352
Autor:
Matthijs Wesseling, Peter Kronenberger, Philippe Giron, Fatima Haddouchi, Gudrun Walser, Albert-Menno Laffra, Alfiah Noor, Jacques De Greve
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-7 (2018)
BMC Research Notes
BMC Research Notes
Objective Our aim was to produce a mono-biotinylated single domain antibody (‘nanobody’) specific for the epidermal growth factor receptor (EGFR), which is overexpressed in many cancer cells. The binding of the nanobody and its function are teste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28cc7b45e1d96a6f1b0ce6e8709c919
https://doi.org/10.1186/s13104-018-3852-1
https://doi.org/10.1186/s13104-018-3852-1
e14104 Background: TNF-related apoptosis-ligand (TRAIL) can selectively induce apoptosis in cancer cells without causing damage to normal cells. However, some tumors are resistant to TRAIL monotherapy and clinical studies assessing targeted agents to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a20722743ae63f63052c741f0dd4a84
https://doi.org/10.1200/jco.2017.35.15_suppl.e14104
https://doi.org/10.1200/jco.2017.35.15_suppl.e14104
Autor:
Gang Chen, Marc Bracke, Olivier De Wever, Erik Teugels, Ijeoma Adaku Umelo, Alfiah Noor, Peter Kronenberger, Jacques De Greve
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 90(2)
Introduction Lung cancer remains the leading cause of cancer-related mortality worldwide, with metastatic disease frequently a prominent feature at the time of diagnosis. The role of NSCLC-derived EGFR mutations in cancer cell proliferation and survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6faf1279a9f44a8a825623094f4ece
https://pubmed.ncbi.nlm.nih.gov/26342549
https://pubmed.ncbi.nlm.nih.gov/26342549
Autor:
Kshitiz Singh, Peter Kronenberger, Alfiah Noor, Olivier De Wever, Marc Bracke, Gang Chen, Ijeoma Adaku Umelo, Jan Van Deun, Jacques De Greve, Erik Teugels
Publikováno v:
Oncotarget
ONCOTARGET
ResearcherID
Vrije Universiteit Brussel
Europe PubMed Central
ONCOTARGET
ResearcherID
Vrije Universiteit Brussel
Europe PubMed Central
// Ijeoma Adaku Umelo 1 , Olivier De Wever 2 , Peter Kronenberger 1, 3 , Jan Van Deun 2 , Alfiah Noor 1 , Kshitiz Singh 4 , Erik Teugels 1 , Gang Chen 1 , Marc Bracke 2 , Jacques De Greve 1 1 Laboratory of Molecular Oncology and Department of Medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::627f69838ed110b86f9ed08788f1bb63
https://pubmed.ncbi.nlm.nih.gov/25992771
https://pubmed.ncbi.nlm.nih.gov/25992771
Publikováno v:
Journal of Virology. 72:1354-1364
Intercellular adhesion molecule 1 and the low-density lipoprotein receptor are used for cell entry by major and minor receptor group human rhinoviruses (HRVs), respectively. Whereas minor-group viruses, exemplified by HRV2, transfer their genomic RNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905f8fad7767ef89c70e3bed4197a957
https://doi.org/10.1128/jvi.72.2.1354-1364.1998
https://doi.org/10.1128/jvi.72.2.1354-1364.1998